about
BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with unmet medical needs. Its two cell therapy platforms derived from the bone marrow. CardiAMP aut...
Read More
0.83
-0.03
(-3.49%)
186.2K
XNAS Volume
XNAS 17 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
BioCardia Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..